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Research
Chronic exposure to arsenic is a significant 
worldwide environmental health concern 
[Agency for Toxic Substances and Disease 
Registry (ASTDR) 1999; National Research 
Council 1999]. Contamination of drink-
ing water by natural geologic sources of As 
is the primary route of exposure. The U.S. 
Environmental Protection Agency (EPA) 
standard for drinking water As exposure was 
recently reduced to 10 ppb (0.13 µM) (U.S. 
EPA 2001). However, this standard does not 
cover private wells. In many areas of the United 
States As is naturally found at levels higher 
than the federal guidelines, and a signifi  cant 
portion of the population may be drinking 
excess As chronically (Karagas et al. 2002). This 
may represent as many as 25 million people in 
the United States, and worldwide hundreds 
of millions of people are exposed to levels of 
As far above 10 ppb. In addition, significant 
biological effects of As have been observed 
in cell culture and in animal models at and 
below the current 10-ppb U.S. EPA standard 
(Andrew et al. 2007; Kozul et al. 2009; Lantz 
et al. 2007; Straub et al. 2008).
Chronic exposure to As has been associ-
ated with many diseases, including lung, liver, 
skin, kidney, and bladder cancer; cardio-
vascular disease; diabetes; and reproductive and 
developmental defects (Abernathy et al. 1999; 
National Research Council 1999; Smith et al. 
1992; Tapio and Grosche 2006; Watanabe 
et al. 2003). Multiple mechanisms have been 
associated with As-induced disease risk, includ-
ing endocrine disruption, oxidative stress, and 
alterations in cell signaling and DNA repair 
(Andrew et al. 2006; Aposhian and Aposhian 
2006; Kaltreider et al. 2001; Rossman 2003). 
However, differences in dose, time, and tissue, 
as well as coexposures, can result in differing 
mechanisms and complicate the interpretation 
of disease risk under varying exposure con-
ditions. Recent reports have indicated that 
chronic As exposure in human populations 
results in an increased risk of a variety of lung 
diseases, including impaired lung function, 
bronchiectasis, lung cancer, and other respira-
tory illnesses (Ghosh et al. 2007; Raqib et al. 
2009; Smith et al. 2006). The ability of As 
to increase the risk of lung disease through 
ingestion, as opposed to inhalation, makes it a 
unique and intriguing lung toxicant.
Arsenic has been identified as a potent 
immuno  modulatory agent in many experi-
mental models and epidemiologic studies 
(Andrew et al. 2008; Hernandez-Castro et al. 
2009; Lemarie et al. 2006; Nayak et al. 2007; 
Zhou et al. 2006). We recently showed that 
chronic low-dose As exposure can profoundly 
alter the gene and protein expression of many 
regulators of the innate immune system in a 
mouse model of exposure (Kozul et al. 2009). 
We hypothesized that As-induced alterations 
on the immune system in the lung will lead 
to a compromised response to a subsequent 
immune challenge. In the present study, we 
tested this hypothesis by investigating whether 
chronic low-dose As exposure could affect the 
severity of influenza A (H1N1) infection in a 
murine model. Based on our previous studies, 
we were specifically interested in the innate 
immune response to infection, including the 
migration capability of innate immune cells, 
such as dendritic cells (DCs). DCs are antigen- 
presenting cells (APCs) that activate naive 
T cells, and their functioning is critical to 
the initiation of a primary immune response. 
With particular respect to the lung, where 
there is persistent exposure to environmental 
pathogens, DCs are constantly sampling the 
environ  ment, processing antigen, and control-
ling tolerance, demonstrating their indispens-
able role in immune regulation.
Respiratory infections with influenza 
are a significant public health concern and 
a major cause of morbidity and mortality 
worldwide (Fauci 2005). It has been esti-
mated that 5–15% of the population will 
contract influenza infection annually, result-
ing in > 3–5 million hospitalizations and 
between 250,000 and 500,000 deaths world-
wide (World Health Organization 2009). 
Identifying risk factors, including environ-
mental exposures, such as As, could have a 
substantial and immediate impact on public 
health (Lawrence 2007). Additionally, the 
impact of As exposure on the potential for a 
pandemic flu outbreak is of particular con-
cern, considering that many of the geographic 
areas with confirmed human cases of avian flu 
or H1N1 (swine) flu are known to include 
populations that also have significantly ele-
vated As exposures, such as in Southeast Asia 
and Mexico. The recent outbreak of H1N1 
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flu in Mexico and across the world has demon-
strated the impact a pandemic flu can have on 
global populations. Age and under  lying medi-
cal conditions influence susceptibility and 
severity of infection; however, these factors 
cannot account for the extreme variability 
observed in response to influenza infection. 
Many questions have been raised concerning 
the increased mortality as a result of H1N1 
infection in Mexico compared with relatively 
mild disease in other infected populations. 
There is growing evidence that exposure to 
environmental toxicants, including dioxin and 
cigarette smoke, can dramatically alter anti-
viral responses (Burleson et al. 1996; Gualano 
et al. 2008; Warren et al. 2000). In the pres-
ent study, we show that chronic low-dose As 
exposure can profoundly alter the response 
to H1N1 infection. Understanding the role 
of As in response to such viral challenges will 
be important in the overall assessment of the 
public health risk.
Materials and Methods
Animal husbandry. All animal studies were 
conducted in accordance with guidelines 
approved by the Association for Assessment 
and Accreditation of Laboratory Animal Care 
using a protocol approved by the Institutional 
Animal Care and Use Committee (IACUC) 
at Dartmouth Medical School. All animals 
were treated humanely and with regard for 
alleviation of suffering. Seven-week-old 
C57BL/6J male mice (Jackson Laboratories, 
Bar Harbor, ME) were housed on Carefresh 
bedding (International Absorbents, Inc., 
Ferndale, WA) in autoclaved cages and fed 
AIN-76A diet (Harlan-Teklad, Madison, WI) 
ad libitum. Background As concentrations in 
the diet were < 20 ppb (Kozul et al. 2008). 
At the start of the experiment, animals were 
given drinking water (ad libitum; water was 
changed weekly) with or without the addi-
tion of 100 ppb sodium arsenite. Mice were 
maintained on control or 100-ppb As water 
throughout the course of infection.
Influenza virus infection. After 5 weeks of 
As exposure, mice were anesthetized with 9:1 
ketamine:xylazine mix at 0.1 mL/30 g body 
weight and inoculated intranasally with one-
half the median lethal dose of standard labo-
ratory influenza A virus A/PuertoRico/8/34 
(H1N1) strain (Flu). Morbidity (measured 
as weight loss) was monitored daily over the 
course of infection. Body weight loss > 20% 
was the end point for termination from the 
study in compliance with IACUC guidelines.
Viral titer. Whole lungs from infected mice 
were homogenized, snap frozen, and stored at 
–80°C. We quantified influenza virus titers in 
whole-lung homogenate using TCID50 (50% 
tissue culture infective dose) determination. 
Briefly, 10× serial dilutions of lung samples 
were added in triplicate to Madin-Darby 
canine kidney (MDCK) cells in a 96-well plate, 
and plates were incubated at 37°C for 5 days. 
Infected cells were identified by chicken red 
blood cell hemagglutination.
Bronchoalveolar lavage fluid (BALF). Lungs 
were lavaged in situ with 1 mL phosphate- 
buffered saline (PBS). Remaining cells were 
collected with four sequential washes. We cen-
trifuged BALF and combined cells retrieved 
from all five washes. We used a hemo  cytometer 
with trypan blue exclusion to obtain total 
cell counts (excluding non  nucleated cells). 
Cytospin preparations were stained using the 
Protocol Hema 3 stain set (Fisher, Houston, 
TX). Measurements of cytokine and albumin 
levels in BALF were assessed from the first 
1 mL of BALF only. We used the albumin 
ELISA kit (Bethyl Labs, Montgomery, TX) to 
assay albumin concentrations in BALF follow-
ing the manufacturer’s instructions.
Mediastinal lymph node (MLN) cell sus-
pensions. We prepared cell suspensions from 
the MLNs by gentle mincing and digestion in 
collagenase (1 mg/mL, type II; Worthington 
Biochemical Corp., Lakewood, NJ) and DNase 
(0.02 mg/mL, grade II from bovine pancreas; 
Roche, Manheim, Germany) for 45 min at 
room temperature, followed by the addition of 
EDTA (0.1 M) for an additional 5 min.
Peripheral blood oxygen saturation (SpO2). 
We measured SpO2 using the MouseOx sys-
tem (Starr Life Sciences Corp., Allison Park, 
PA) according to the manufacturer’s protocol. 
Conscious mice were restrained, and the sen-
sor was placed at the base of the tail. Mice 
were acclimated in the restraint, and data were 
collected for a period of 10 sec per mouse. 
Flow cytometry. We collected BALF and 
MLN single-cell suspensions as described 
above. Red blood cells were lysed by incu-
bation with buffered ammonium chloride 
solution. FITC (fluorescein isothiocyanate)–
conjugated CD4, PerCpCy5.5-conjugated 
CD8,  APC-conjugated  CD11c,  and 
PerCpCy5.5-conjugated B220 antibodies 
were purchased from eBioscience (San Diego, 
CA). Biotin-conjugated CD103 antibody was 
purchased from BioLegend (San Diego, CA). 
Samples were run on FACSCalibur cytometer 
(BD Biosciences, San Jose, CA), and all data 
were analyzed with FlowJo software (Tree 
Star, Ashland, OR).
Cytokine profile analysis. We analyzed 
cell-free BALF using the Bio-Plex suspen-
sion array system using fluorescently dyed 
Luminex microspheres beads (Bio-Rad, 
Hercules, CA). Cytokines and chemokines 
Figure 1. Morbidity of influenza infection (measured by weight loss) in mice exposed to control water 
or water containing 100 ppb As. One experiment was conducted for days 0–16 (n = 6–8 per group), and 
three additional experimental repeats were conducted for days 0–7 (n = 6 per group per experiment). See 
“Materials and Methods” for experimental details. Values shown are mean ± SEM. The p-value for overall 
significance between groups exposed to flu alone or As + flu is p < 0.0001 (two-way ANOVA). 
**p < 0.01, and #p < 0.001, for individual time point exposures.
105
100
95
90
85
80
P
e
r
c
e
n
t
 
b
o
d
y
 
w
e
i
g
h
t
02 345 67891 01 11 21 31 41 51 61 7 1
Days p.i.
Flu alone
Flu + As
#
#
#
#
#
** ** **
Figure 2. Viral titers for flu on day 7 p.i. in mice 
exposed to control water or water contain-
ing 100 ppb As. Whole-lung homogenates were 
assessed for viral titers by the TCID50 method. See 
“Materials and Methods” for experimental details. 
Values shown are mean ± SEM from two experi-
mental repeats (n = 3–6 per group).
*p < 0.05 by two-tailed Student’s t-test.
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measured in this study were interleukin-1β 
(IL-1β), IL-6, macrophage inflammatory 
protein 1α (MIP-1α), RANTES, mono-
cyte chemo  attractant protein 1 (MCP-1), 
IL-10, macro  phage-colony–stimulating factor 
(M-CSF), macrophage inflammatory pro-
tein-2 (MIP-2), macro  phage inflammatory 
protein 1β (MIP-1β), and tumor necrosis 
factor-α (TNFα). BALF samples were assayed 
in duplicate. Cytokine/chemokine standards 
were prepared in PBS and were assayed in 
triplicate. The assay was performed according 
to manufacturer protocol. 
DC isolation and culture. The DC culture 
protocol was described previously (Castellino 
et al. 2000) and is a modification of that 
described by Inaba et al. (1993). Briefly, bone 
marrow cells were collected from the femurs 
of C57Bl/6J mice exposed to drinking water 
with or without 100 ppb As for 5 weeks (in 
the absence of infection). Cells were resus-
pended at 106 cells/mL in RPMI 1640 
medium [10% heat-inactivated fetal bovine 
serum, 100 U/mL penicillin/streptomycin, 
50 mM β-mercaptoethanol, 5% cell culture 
supernatant from X63 cells secreting granulo-
cyte M-CSF (GM-CSF)]. Cells were plated at 
2 mL/well into 12-well plates, and all cells were 
cultured in the absence of As. On days 2, 4, 
and 6, the cells were washed, non  adherent cells 
were removed, and fresh medium was applied. 
On day 7, cells were scraped and collected for 
transwell migration assays.
Transwell migration assay. On day 7, bone 
marrow cells were counted with trypan blue 
exclusion using a hemocytometer to assess sur-
vival. We observed no differences in cell sur-
vival between cells isolated from control and 
As-exposed mice. Transwell plates (6.5-mm-
diameter insert, 8.0-µm pore size, poly  carbonate 
membrane; Corning Costar, Corning, NY) 
were precoated with 2 µg/mL fibronectin, and 
500 µL 10 µM ADP was added to the bot-
tom well; 100,000 cells were added in serum-
free medium to the top chamber of a transwell 
plate and allowed to migrate for 2 hr. After 
the migration period, we removed any cells 
remaining on top of the membrane and rinsed 
the membranes with PBS. Migrated cells were 
fixed, permeabilized with 0.01% Triton X-100 
(Sigma, St. Louis, MO), and stained with 
crystal violet (Sigma). The membranes were 
mounted on microscope slides for analysis. We 
used a Q-Fired cooled CCD camera attached 
to an Olympus microscope to capture 10 ran-
dom fields per membrane. Migrated cells were 
counted with SigmaScan Pro imaging anal-
ysis software (Systat Software, Chicago, IL). 
Counts for all 10 fields were averaged to give a 
mean cell count for each membrane. All experi-
ments were completed at least three times with 
n = 3 per trial.
Statistical analysis. Statistical analysis was 
performed with GraphPad Prism, version 5.0a 
for Macintosh (GraphPad Software Inc., 
La Jolla, CA) using a two-tailed unpaired t-test 
with 95% confidence interval and one-way 
analysis of variance (ANOVA; (p < 0.05 was 
considered significant). 
Results
As shown in Figure 1, after a 5-week expo-
sure to 100 ppb As in drinking water, mice 
infected with influenza A (H1N1) displayed 
a significant increase in morbidity. By day 8 
post  infection (p.i.), the As-exposed mice 
displayed such severe morbidity (e.g., body 
weight decrease ≥ 20%) that those experimen-
tal groups were euthanized in compliance with 
institutional IACUC standards. Because of the 
severity of these responses, sub  sequent analyses 
focused on day 3 and day 7 p.i. In contrast, a 
parallel group of control mice infected with 
influenza but not exposed to As displayed a 
moderate weight loss, but then began to recover 
weight by day 10 p.i., with complete weight 
recovery by day 16 p.i. (Figure 1). Exposure 
to As alone in the absence of viral infection 
did not influence weight or growth over the 
5-week period, nor did anesthesia alone, with 
or without respiratory exposure vehicle, in 
either the control or As-exposed mice (data not 
shown). Thus, the increased morbidity was due 
to the combination of As in drinking water 
and influenza infection at an infectious dose at 
which mice not exposed to As recover.
Given that the inability to properly clear 
virus from the lung is positively correlated 
with increased risk of adverse outcomes, we 
examined the levels of influenza A virus in 
whole-lung homogenates using TCID50 
determination at day 7 p.i. Relative to 
As-unexposed controls, the As-exposed mice 
exhibited a significant 10-fold increase in viral 
titers at this time point, correlating with their 
relative increase in morbidity (Figure 2).
At day 7 p.i., obvious gross histologic 
changes in the As-exposed mice, including 
edema and hemorrhaging, could be observed 
by visual inspection of the whole lung 
(Figure 3A,B). We meas  ured capillary leakage 
into the lungs by assaying albumin concentra-
tions in the BALF. Albumin concentrations 
were significantly increased in the As-exposed 
versus unexposed mice at day 7 p.i. Albumin 
concentrations did not differ between con-
trol or As-exposed mice before infection or at 
day 3 p.i. (Figure 3C). Because an increased 
severity of influenza infection often correlates 
with a decrease in SpO2, we meas  ured the 
oxygen saturation levels in infected control 
and As-exposed conscious mice at day 7 p.i. 
The As-exposed mice displayed a significant 
decrease in SpO2 levels compared with control 
Figure 3. Effect of chronic exposure to As (100 ppb) in drinking water for 5 weeks followed by inocu  la  tion 
with influenza A. (A, B) Gross histology of representative lungs from mice given control drinking water (Flu 
alone; A) and As in drinking water (Flu + As; B) at day 7 p.i. after lungs were perfused with PBS and inflated. 
(C) BALF assessed for albumin by ELISA on day 0 and day 3 and day 7 p.i. (D) Oxygen saturations measured 
with the MouseOx system at day 0 and day 7 p.i. In B and C, values are mean ± SEM from one representative 
experiment (n = 6 per group).
**p < 0.01, and #p < 0.001, by two-tailed Student’s t-test. 
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mice (Figure 3D). The average SpO2 reading 
for the control mice infected with influenza 
was 95.2% (range, 93–97.5%), and the aver-
age SpO2 reading for As-exposed mice infected 
with influenza was 82.9% (range, 75–90%). 
Three of the six As-exposed mice had SpO2 
readings considered to be dangerously low 
(i.e., ≤ 80%). Exposure to As in the absence 
of infection had no effect on peripheral oxygen 
saturation levels.
We investigated cellular infiltration into 
the lungs at 36 hr and at day 3 and day 7 
p.i. We previously reported that exposure to 
100 ppb As for 5 weeks in uninfected mice 
did not induce changes in the total number 
of cells recovered from BALF, nor did it alter 
gross changes in lung histology (Andrew et al. 
2007; Kozul et al. 2009). However, in the 
present experimental model, we observed sig-
nificant differences in the total number of 
cells recovered post  infection from the BALF 
of control and As-exposed mice. At 36 hr and 
day 3 p.i., As-exposed mice had a significant 
decrease in the total number of cells recovered 
from the BALF compared with control mice. 
Conversely, at day 7 p.i., As-exposed mice had 
a significant increase in the number of cells in 
BALF (Figure 4A) relative to controls.
To assess whether changes in total cell 
populations were accompanied by changes 
in the specific cell types recruited to the 
lung, we conducted a morphologic analysis 
of the cells after staining cytospin prepara-
tions. Representative cytospin prepara  tions 
are shown in Figure 5A–F. The total number 
of macrophages (Figure 4B) and neutrophils 
(Figure 4C) were significantly decreased at 
the early stages of infection and increased at 
day 7 p.i. in As-exposed mice compared with 
controls, whereas lymphocytes were decreased 
in the As-exposed mice at day 3 p.i. but were 
similar to controls at day 7 p.i. (data not 
shown). In addition to these differences in cell 
number, the percentages of these different cell 
types within the total cells recovered from the 
BALF also changed, as shown in Figure 4D.
Although the absolute number of lympho-
cytes was largely unaffected at day 7 p.i., when 
subtypes within the lymphocyte popu  lations 
were analyzed by flow cytometry, CD8+ cells 
were significantly increased in terms of both 
cell percentages (Figure 6B) and total cell num-
bers (Figure 6C) in As-exposed mice relative to 
controls. The percentage of CD4+ T cells did 
not differ by As exposure (data not shown).
We previously reported that As exposure 
decreased basal cytokine levels in the lungs 
of uninfected mice (Kozul et al. 2009). In 
the present study we used a Bio-Plex assay 
to examine cytokine production in BALF at 
days 3 and day 7 p.i. We examined a panel of 
10 cytokines: IL-1β, IL-6, MIP-1α, RANTES, 
MCP-1, IL-10, M-CSF, MIP-2, MIP-1β, 
and TNFα. With the exception of MIP-1α, 
Figure 5. Effects of flu alone and flu plus chronic exposure to As (100 ppb) in drinking water shown at 36 hr, 
day 3, and day 7 p.i. in representative cytospin preparations. See “Materials and Methods” for experimental 
details. (A, C, E) Flu alone. (B, D, F) Flu + As. (A, B) 36 hr p.i. (C, D) Day 3 p.i. (E, F) Day 7 p.i.
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Figure 4. Alteration in cell numbers at day 0, 36 hr, day 3, and day 7 p.i. in BALF of mice exposed to control 
water or water containing 100 ppb As (Flu + As) followed by inoculation with influenza A. (A) Number of 
viable nucleated cells recovered from BALF. (B, C) Extrapolation of the total number of macro  phages (B) 
and neutrophils (C) recovered from BALF. See “Materials and Methods” for experimental details. For A–C, 
data represent mean ± SEM from one representative experiment (n = 5–6 per group). (D) Neutrophils, 
macro  phages (Macs), and lympho  cytes shown as percentages of the total cells recovered. 
*p < 0.05, **p < 0.01, and #p < 0.001 determined by two-tailed Student’s t-test.Arsenic and respiratory infection
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cytokine production had the same general pat-
tern. We observed no significant differences 
between the control and As-exposed mice at 
day 7 p.i. However, we observed a significant 
decrease in the As-exposed mice relative to 
controls in 9 of the 10 cytokines at day 3 p.i. 
(Figure 7). In some cases, such as IL-1β and 
TNFα, cytokine production was below the 
limits of assay detection in the As-exposed 
mice. MIP-1α levels were below detection at 
day 3 p.i. in all mice but indicated a trending 
increase in the As-exposed animals relative to 
controls at day 7 p.i. (data not shown).
The early recruitment of DCs to the lymph 
node is essential for the proper initiation of an 
immune response, and we previously reported 
that As exposure decreases the expression of 
genes involved in cell adhesion and migration 
(Kozul et al. 2009). Therefore, to determine 
whether the migration of DCs to the lymph 
node was impaired by As exposure, we analyzed 
the MLNs for DC populations at day 3 p.i. 
Single-cell suspensions from MLNs were 
assessed for the DC markers CD11c+/CD103+ 
and CD11c+/B220+. We observed a significant 
decrease in the total number of cells recovered 
from the MLNs in the As-exposed mice rela-
tive to controls at day 3 p.i. (Figure 8A). Flow 
cytometry staining for CD11c+/CD103+ and 
CD11c+/B220+ DCs also indicated that these 
DC populations were significantly decreased in 
MLNs of As-exposed mice compared with con-
trols at day 3 p.i. (Figure 8B,C). We observed 
no differences in the intensity of the staining 
(data not shown).
We then assessed effects of As on DC 
migration capacity, using primary bone mar-
row DCs isolated from control mice and mice 
exposed to 100 ppb As for 5 weeks (in the 
absence of influenza infection). Cells were cul-
tured for 7 days in the presence of GM-CSF 
to produce immature DCs. Relative to con-
trols, cells isolated from As-exposed mice had 
a significant decrease in migration capability 
toward ADP in a transwell assay (Figure 8D), 
indicating that As alone can compromise 
Figure 6. Effects of chronic exposure to As (100 ppb) in drinking water on CD8+ cells in BAL in response 
to influenza A. (A) Representative fluorescence-activated cell sorting plots showing isolated BALF cells 
stained with fluorochrome-conjugated antibodies against CD4 and CD8. (B, C) Percentage of CD8+ cells 
(B) and average number of total CD8+ cells (C) recovered from BALF at day 7 p.i.; values shown are mean ± 
SEM from one representative experiment (n = 5–6 per group).
*p < 0.05, determined by two-tailed Student’s t-test.
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aspects of immune cell function and that this 
then manifests as a significantly altered innate 
immune response after viral infection.
Discussion
To determine whether chronic low-dose 
drinking water As exposure compromises 
the immune response to respiratory infec-
tion, we analyzed the outcome of influenza 
A (H1N1) infection in mice drinking water 
containing 100 ppb As. Our studies dem-
onstrated that As exposure had a significant 
impact on the immune system, resulting in 
a severely compromised response to influ-
enza A infection and increased morbidity. 
We also observed increased viral titers, capil-
lary leakage, altered cellular responses, and 
decreased cytokine production and oxygen 
saturations in the As-exposed mice relative to 
controls. At early time points postinfection, 
we observed that As-exposed mice had an 
attenuated response. Conversely, by the later 
time points, the As-exposed mice displayed 
an excessive cellular inflammatory response 
to infection, indicated by significant increases 
in the number of cells within the lung and 
increases in markers of lung injury, such as 
BALF albumin concentrations and decreased 
oxygen saturations compared with controls.
We expected the initial attenuated 
immune response in the As-exposed mice 
based on our previous results (Kozul et al. 
2009). As exposure affects a variety of aspects 
of host defense, including responses of macro-
phages (Lemarie et al. 2006), lymphocytes 
(Andrew et al. 2008; Hernandez-Castro et al. 
2009), and airway epithelial cells (Olsen et al. 
2008). Additionally, an appropriate and suf-
ficient response to an infectious challenge 
requires integration of the innate and adaptive 
immune defenses. Given that As exposure has 
important impacts on both components, it is 
not unexpected that the effects of As exposure 
on the immune response to viral infection 
are complex. It is therefore likely that several 
mechanisms contributed to the adverse out-
comes observed in the As-exposed mice.
The switch from an inadequate innate 
immune response at early time points to 
an excessive response at later time points is 
intriguing, and the underlying mechanism for 
this biphasic response warrants future inves-
tigation. The excessive response at late time 
points was also accompanied by considerable 
hemorrhaging and leakage within the lung. It 
does not appear that this switch was principally 
chemokine driven, because we observed that 
chemokine levels were not increased at day 
7 p.i. Moreover, at this time point there were 
two to three times more cells in the lungs of the 
As-exposed mice compared with controls, sug-
gesting that cytokine and chemokine produc-
tion may still be decreased on a per cell basis. 
However, given that cytokine and chemokine 
production is a dynamic process, we cannot 
exclude that an increase in cytokine production 
may have occurred but was not detected at the 
time points investigated in this study. It is pos-
sible that the increased number of macrophages 
and neutrophils at day 7 p.i. may have resulted 
from a compensatory innate response that was 
not properly initiated early in the course of 
infection. An overly exuberant macrophage 
and neutro  phil response has also been observed 
with highly pathogenic strains of influenza, 
such as H5N1 (Perrone et al. 2008) and the 
1918 strain (Kobasa et al. 2007). Nevertheless, 
the lymphocyte response was ineffective in 
controlling levels of virus within the lung, 
because the titers were increased 10-fold in 
the As-exposed mice relative to control mice 
at day 7 p.i. The increased viral titers in con-
junction with the increase in CD8+ cells in 
the As-exposed mice suggest the possibility 
that the CD8+ cells may not have been fully 
capable of expressing antiviral effector activi-
ties. Alternatively, the impaired innate response 
may have resulted in unhindered viral repli-
cation that even an exaggerated CD8+ T-cell 
response could not effectively control. It is dif-
ficult to assess the role of CD8+ T cells in the 
response using this model because of the high 
morbidity in the As-exposed mice.
We have also shown that As decreased 
cell migration, which suggests that the critical 
components of this response were defective. 
With respect to respiratory viral infection, DC 
migration to the regional lymph nodes early 
in the course of infection is a critical com-
ponent for initiating an appropriate immune 
defense against influenza infection (Legge 
and Braciale 2003). The CD11c+/B220+ 
DCs in the mouse lymph node are presump-
tively immature plasma  cytoid DCs, which 
are capable of producing large amounts of 
type I interferon (Nakano et al. 2001; Siegal 
et al. 1999). The CD11c+/CD103+ DCs 
have been shown to reside in lung mucosa 
(Sung et al. 2006). The relative decrease in 
this population of DCs in the lymph nodes 
may have contributed to the initial attenuated 
response of As-exposed mice and suggests that 
antigen presentation within the lymph node 
from this subset of resident lung DCs may 
have been compromised. Defective migration 
by bone-marrow–derived DCs isolated from 
uninfected As-exposed mice demonstrated 
that As exposure alone compromised criti-
cal functional components of the innate host 
defense mechanisms, which would likely have 
affected responses to many pathogens and 
other pathologic conditions.
The immune response against pathogens 
is a tightly regulated equilibrium, requiring 
precise management of effectively clearing 
pathogen while minimizing immunopatho-
logic damage to the host (Bachmann and 
Kopf 2002). Therefore, it is not unexpected 
that the initial impairment in an appropriate 
immune response due to As exposure could 
have significant consequences on the ability to 
clear influenza infection, whereas prolonged 
viral carriage may predispose to enhanced 
tissue injury. To our knowledge, this is the 
first report showing that chronic low-dose As 
exposure significantly impairs the immune 
system, and specifically DCs, in response to a 
respiratory virus infection. Further investiga-
tion into mechanisms and the effects at lower 
doses of As, such as 10 ppb, will be the basis 
of future studies. We also hypothesize that As 
exposure will predispose individuals to aber-
rant responses to other types of infection. In 
addition to the potential acute effects reported 
in this study, these aberrant responses may 
place exposed individuals at risk for develop-
ment of other chronic lung diseases such as 
bronchiectasis, which has been reported to be 
significantly elevated in As-exposed popula-
tions (Smith et al. 2006). These results also 
suggest that chronic As exposure, particularly 
in areas of Southeast Asia and Mexico, may 
be a factor that could enhance the potential 
impact of a pandemic strain of influenza if it 
should emerge in the human population.
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